As previously announced, Pfizer shares will be traded in the same manner as all of the other shares on the Exchange. However, the company's shares will not be listed on Stockholmsbörsen. Trading will be conducted in Swedish kronor (SEK) via Stockholmsbörsen's SAXESS(TM) trading system. Pfizer will be traded on the Xterna list, a new list for non- Swedish companies. To ensure that trading in Pfizer shares maintains satisfactory liquidity, a market maker will make buy and sell prices continuously available.
Pfizer's primary listing is on the New York Stock Exchange (NYSE). No agreement will exist between Stockholmsbörsen and Pfizer. Among other effects, this will mean that Stockholmsbörsen's regulations in regard to the disclosure of information to the Swedish market will not apply. Through an exchange message or a press release, Stockholmsbörsen will provide information about the initial day of trading in Pfizer shares, as soon as the stock swap has been completed. For further information, please contact Torsten Örtengren, Head of Listing, tel +46 (0)8 405 70 40 Maria Andark, VP Corporate Communication, Stockholmsbörsen, tel +46 (0)8 405 73 50
The banks and stockbrokers also have additional information about the special terms and conditions applying to holdings of Pfizer shares. More information about trading in Pharmacia and Pfizer shares is available on www.stockholmsborsen.se
